๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma

โœ Scribed by Ronald G. Steis; Kenneth A. Foon; Dan L. Longo

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
661 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ifosfamide in the treatment of high-grad
Ifosfamide in the treatment of high-grade recurrent non-hodgkin's lymphomas
โœ Ian Magrath; Melissa Adde; John Sandlund; Vinay Jain ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 491 KB ๐Ÿ‘ 1 views

We report the results of two phase I1 trials of ifosfamide in very high risk patients with either partially responsive or recurrent non-Hodgkin's lymphomas. In the first study, in which patients were extremely heavily pretreated (50 per cent had received a very intensive salvage regimen containing v

Cladribine in the treatment of advanced
Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma
โœ Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espin ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 2 views

## BACKGROUND. Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.

Cytomegalovirus retinitis and low-grade
Cytomegalovirus retinitis and low-grade non-Hodgkin's lymphoma: Case report and review of the literature
โœ Derzko-Dzulynsky, L.A.; Berger, A.R.; Berinstein, N.L. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

Patients with non-Hodgkin's lymphoma may develop retinal or choroidal lesions during the course of their disease. New immunosuppressive therapies currently used in reticuloendothelial malignancies have increased the incidence of opportunistic infections in this patient population. The differentiatio

Low dose fractionated whole body irradia
Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma
โœ Noah C. Choi; Adrian R. Timothy; Sheldon D. Kaufman; Robert W. Carey; Alan C. Ai ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 506 KB

Thirty-nine patients with advanced non-Hodgkin's lymphoma (38 patients with lymphocytic lymphoma and 1 patient with mixed lymphocytic and histiocytic lymphoma) were treated by fractionated low dose whole body irradiation (WBI) with a minimum follow-up of 8 months. Twenty-eight patients had no previo